Xtl Biopharmaceuticals Ltd (XTLB) Annual Balance Sheets

Annual · GAAP · USD millions
Access XTLB quarterly Balance Sheets →
This page allows investors to track Xtl Biopharmaceuticals Ltd's balance sheet development across multiple reporting periods.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash And Cash Equivalents0.37
Marketable Securities0.00
Cash & Short-term Investments0.00
Accounts receivable0.10
Other Current Assets0.00
Total Current Assets1.34
Equipment/Property/Plant Net0.19
Goodwill net3.19
Intangible Assets3.82
Other Assets, Noncurrent0.00
Current Marketable Securities0.61
Other Current Receivables0.00
Intangible Assets Other Than Goodwill0.38
Total Assets8.55
Liabilities
Total Current Liabilities2.21
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities2.21
Stockholders' Equity
Other Reserves0.02
Retained Earnings-158.25
Additional Paid In Capital Common Stock0.00
Other Equity0.00
Common Stockholder's Equity5.44
Total Stockholder's Equity5.44
Liabilities & Stockholder's Equity8.55
4 historic quarters locked

Sign in to unlock the full Xtl Biopharmaceuticals Ltd balance sheet history.

About Xtl Biopharmaceuticals Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-073831

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License